Levin Capital Trilogy Master Fund, Ltd. - Net Worth and Insider Trading

Levin Capital Trilogy Master Fund, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Levin Capital Trilogy Master Fund, Ltd. owns 1 companies in total, including Standard BioTools Inc (LAB) .

Click here to see the complete history of Levin Capital Trilogy Master Fund, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Levin Capital Trilogy Master Fund, Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
LAB	Standard BioTools Inc	2016-10-14	10 percent owner & other: Passive Investor

Levin Capital Trilogy Master Fund, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Levin Capital Trilogy Master Fund, Ltd. Ownership Network

Ownership Network List of Levin Capital Trilogy Master Fund, Ltd.

No Data

Ownership Network Relation of Levin Capital Trilogy Master Fund, Ltd.

Levin Capital Trilogy Master Fund, Ltd. Owned Company Details

What does Standard BioTools Inc do?

Who are the key executives at Standard BioTools Inc?

Levin Capital Trilogy Master Fund, Ltd. is the 10 percent owner & other: Passive Investor of Standard BioTools Inc. Other key executives at Standard BioTools Inc include director & 10 percent owner Casdin Partners Master Fund, L.p. , SVP & Chief Financial Officer Jeffrey G. Black , and director & 10 percent owner Eli Casdin .

Standard BioTools Inc (LAB) Insider Trades Summary

Over the past 18 months, Levin Capital Trilogy Master Fund, Ltd. made no insider transaction in Standard BioTools Inc (LAB). Other recent insider transactions involving Standard BioTools Inc (LAB) include a net purchase of 3,403,475 shares made by Casdin Partners Master Fund, L.p. , a net purchase of 1,200,000 shares made by Eli Casdin , and a net purchase of 85,984 shares made by Jeffrey G. Black .

In summary, during the past 3 months, insiders sold 0 shares of Standard BioTools Inc (LAB) in total and bought 2,203,475 shares, with a net purchase of 2,203,475 shares. During the past 18 months, 0 shares of Standard BioTools Inc (LAB) were sold and 4,689,459 shares were bought by its insiders, resulting in a net purchase of 4,689,459 shares.

Standard BioTools Inc (LAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Standard BioTools Inc Insider Transactions

No Available Data

Levin Capital Trilogy Master Fund, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Levin Capital Trilogy Master Fund, Ltd.. You might contact Levin Capital Trilogy Master Fund, Ltd. via mailing address: 595 Madison Avenue, 17th Floor, New York Ny 10022.

Discussions on Levin Capital Trilogy Master Fund, Ltd.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.